{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:46:55Z","timestamp":1782172015050,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-026-05142-6","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:18:07Z","timestamp":1777929487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complete pathologic response surrogacy for survival and its predictors in locally advanced rectal cancer: a retrospective cohort study"],"prefix":"10.1007","volume":"41","author":[{"given":"Reza","family":"Ghalehtaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Abyaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Salarvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Sharifian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeim","family":"Nabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setayesh Mostakhdemin","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Nouranifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Javid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima Mousavi","family":"Darzikolaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Behboudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen Ahmadi","family":"Tafti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadsadegh","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Keshvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Kazemeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Keramati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Saraee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Aghili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Kolahdouzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"5142_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"issue":"2","key":"5142_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M et al (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72(2):338\u201344","journal-title":"Gut"},{"issue":"Suppl 2","key":"5142_CR3","doi-asserted-by":"publisher","first-page":"S387","DOI":"10.21037\/jgo-2019-gi-06","volume":"12","author":"BW Vabi","year":"2021","unstructured":"Vabi BW, Gibbs JF, Parker GS (2021) Implications of the growing incidence of global colorectal cancer. J Gastrointest Oncol 12(Suppl 2):S387","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"5142_CR4","first-page":"226","volume":"35","author":"IVA Affleck","year":"2022","unstructured":"Affleck IVA, Koprowski MA, Nabavizadeh N, Tsikitis VL (2022) The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation. Ann Gastroenterol 35(3):226","journal-title":"Ann Gastroenterol"},{"issue":"11","key":"5142_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrclinonc.2011.118","volume":"8","author":"M Aklilu","year":"2011","unstructured":"Aklilu M, Eng C (2011) The current landscape of locally advanced rectal cancer. Nat Rev Clin Oncol 8(11):649\u2013659","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"5142_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123611","volume":"12","author":"F Papaccio","year":"2020","unstructured":"Papaccio F, Rosell\u00f3 S, Huerta M, Gambardella V, Tarazona N, Fleitas T et al (2020) Neoadjuvant chemotherapy in locally advanced rectal cancer. Cancers (Basel) 12(12):3611","journal-title":"Cancers (Basel)"},{"issue":"2","key":"5142_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.47162\/RJME.62.2.07","volume":"62","author":"ST Alexandrescu","year":"2021","unstructured":"Alexandrescu ST, Dumitru AV, Babiuc RD, Costea RV (2021) Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications. Rom J Morphol Embryol 62(2):411","journal-title":"Rom J Morphol Embryol"},{"issue":"11","key":"5142_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.ejso.2017.07.024","volume":"43","author":"K Gash","year":"2017","unstructured":"Gash K, Baser O, Kiran R (2017) Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes. Eur J Surg Oncol 43(11):2052\u20132059","journal-title":"Eur J Surg Oncol"},{"key":"5142_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2482-14-94","volume":"14","author":"IY Kim","year":"2014","unstructured":"Kim IY, You SH, Kim YW (2014) Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer. BMC Surg 14:1\u20137","journal-title":"BMC Surg"},{"issue":"Suppl 2","key":"5142_CR10","doi-asserted-by":"publisher","first-page":"S391","DOI":"10.4103\/jcrt.JCRT_1273_20","volume":"18","author":"A Mehraj","year":"2022","unstructured":"Mehraj A, Baba AA, Khan B, Khan MA, Wani RA, Parray FQ et al (2022) Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer. J Cancer Res Ther 18(Suppl 2):S391\u2013S396","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"5142_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/DCR.0b013e31828e5a72","volume":"56","author":"U Wallin","year":"2013","unstructured":"Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A (2013) CEA\u2013a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer. Dis Colon Rectum 56(7):859\u2013868","journal-title":"Dis Colon Rectum"},{"key":"5142_CR12","doi-asserted-by":"publisher","first-page":"1361300","DOI":"10.3389\/fonc.2024.1361300","volume":"14","author":"X Zhong","year":"2024","unstructured":"Zhong X, Zeng G, Zhang L, You S, Fu Y, He W et al (2024) Prediction of pathologic complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. Front Oncol 14:1361300","journal-title":"Front Oncol"},{"issue":"9","key":"5142_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","volume":"11","author":"M Maas","year":"2010","unstructured":"Maas M, Nelemans PJ, Valentini V, Das P, R\u00f6del C, Kuo L-J et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11(9):835\u201344","journal-title":"Lancet Oncol"},{"issue":"5","key":"5142_CR14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset J-F, Etienne P-L, Rio E, Fran\u00e7ois \u00c9, Mesgouez-Nebout N et al (2021) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(5):702\u201315","journal-title":"Lancet Oncol"},{"issue":"15","key":"5142_CR15","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1200\/JCO.21.01667","volume":"40","author":"J Jin","year":"2022","unstructured":"Jin J, Tang Y, Hu C, Jiang L-M, Jiang J, Li N et al (2022) Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol 40(15):1681","journal-title":"J Clin Oncol"},{"issue":"204","key":"5142_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114044","volume":"1","author":"WH Zwart","year":"2024","unstructured":"Zwart WH, Temmink SJ, Hospers GA, Marijnen CA, Putter H, Nagtegaal ID, Blomqvist L, Kranenbarg EM, Roodvoets AG, Martling A, van de Velde CJ (2024Jun) Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial. European Journal of Cancer. 1(204):114044","journal-title":"European Journal of Cancer."},{"issue":"6","key":"5142_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/01.sla.0000225360.99257.73","volume":"244","author":"NK Kim","year":"2006","unstructured":"Kim NK, Baik SH, Seong JS, Kim H, Roh JK, Lee KY et al (2006) Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg 244(6):1024\u20131030","journal-title":"Ann Surg"},{"key":"5142_CR18","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1245\/s10434-007-9471-z","volume":"14","author":"L-J Kuo","year":"2007","unstructured":"Kuo L-J, Liu M-C, Jian JJ-M, Horng C-F, Cheng T-I, Chen C-M et al (2007) Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 14:2766\u20132772","journal-title":"Ann Surg Oncol"},{"key":"5142_CR19","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1245\/s10434-010-1506-1","volume":"18","author":"LF de Campos-Lobato","year":"2011","unstructured":"de Campos-Lobato LF, Stocchi L, da Luz Moreira A, Geisler D, Dietz DW, Lavery IC et al (2011) Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol 18:1590\u20138","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"5142_CR20","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11605-017-3408-z","volume":"21","author":"A Dinaux","year":"2017","unstructured":"Dinaux A, Amri R, Bordeianou L, Hong T, Wo J, Blaszkowsky L et al (2017) The impact of pathologic complete response in patients with neoadjuvantly treated locally advanced rectal cancer\u2014a large single-center experience. J Gastrointest Surg 21(7):1153\u20138","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"5142_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jso.27316","volume":"128","author":"S Bedrikovetski","year":"2023","unstructured":"Bedrikovetski S, Traeger L, Sammour T (2023) Reply to letter to the editor: can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study. J Surg Oncol 128(1):181\u2013182","journal-title":"J Surg Oncol"},{"issue":"8","key":"5142_CR22","volume":"13","author":"DM McDermott","year":"2021","unstructured":"McDermott DM, Singh SA, Renz PB, Hasan S, Weir J (2021) Predictors of pathologic response after total neoadjuvant therapy in patients with rectal adenocarcinoma: a National Cancer Database analysis. Cureus 13(8):e17233","journal-title":"Cureus"},{"key":"5142_CR23","doi-asserted-by":"publisher","first-page":"1049228","DOI":"10.3389\/fonc.2022.1049228","volume":"12","author":"H Zhang","year":"2022","unstructured":"Zhang H, Cao K, Li G, Zhai Z, Wei G, Qu H et al (2022) Active surveillance in long period of total neoadjuvant therapy in rectal cancer: early prediction of poor regression response. Front Oncol 12:1049228","journal-title":"Front Oncol"},{"issue":"1-2","key":"5142_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/ans.18021","volume":"93","author":"S Bedrikovetski","year":"2023","unstructured":"Bedrikovetski S, Fitzsimmons T, Perry J, Vather R, Carruthers S, Selva-Nayagam S et al (2023) Personalized total neoadjuvant therapy (pTNT) for advanced rectal cancer with tailored treatment sequencing based on clinical stage at presentation. ANZ J Surg 93(1\u20132):173\u201381","journal-title":"ANZ J Surg"},{"issue":"4","key":"5142_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/DCR.0000000000002245","volume":"66","author":"BC Chapman","year":"2023","unstructured":"Chapman BC, Lai SH, Friedrich T, Lieu CH, Moskalenko M, Olsen JR et al (2023) Rectal cancer: clinical and molecular predictors of a complete response to total neoadjuvant therapy. Dis Colon Rectum 66(4):521\u201330","journal-title":"Dis Colon Rectum"},{"key":"5142_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245853","author":"E Flom","year":"2023","unstructured":"Flom E, Schultz KS, Pantel HJ, Leeds IL (2023) The predictors of complete pathologic response in rectal cancer during the total neoadjuvant therapy era: a systematic review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15245853","journal-title":"Cancers (Basel)"},{"issue":"7","key":"5142_CR27","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/bjs.8702","volume":"99","author":"S Martin","year":"2012","unstructured":"Martin S, Heneghan H, Winter D (2012) Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Journal of British Surgery 99(7):918\u2013928","journal-title":"Journal of British Surgery"},{"issue":"8","key":"5142_CR28","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/bjs\/znad094","volume":"110","author":"S Nordkamp","year":"2023","unstructured":"Nordkamp S, Piqeur F, van den Berg K, Tolenaar JL, van Hellemond IE, Creemers G-J et al (2023) Locally recurrent rectal cancer: oncological outcomes for patients with a pathological complete response after neoadjuvant therapy. Br J Surg 110(8):950\u20137","journal-title":"Br J Surg"},{"issue":"10","key":"5142_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.06.014","volume":"49","author":"C Cerd\u00e1n-Santacruz","year":"2023","unstructured":"Cerd\u00e1n-Santacruz C, Cano-Valderrama \u00d3, Ranca\u00f1o RS, Ter\u00e9s LB, Vigorita V, P\u00e9rez TP et al (2023) Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study. Eur J Surg Oncol 49(10):106962","journal-title":"Eur J Surg Oncol"},{"key":"5142_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/867841","author":"S Sinukumar","year":"2014","unstructured":"Sinukumar S, Patil P, Engineer R, Desouza A, Saklani A (2014) Clinical outcome of patients with complete pathological response to neoadjuvant chemoradiotherapy for locally advanced rectal cancers: the Indian scenario. Gastroenterol Res Pract. https:\/\/doi.org\/10.1155\/2014\/867841","journal-title":"Gastroenterol Res Pract"},{"key":"5142_CR31","first-page":"275","volume":"11","author":"TJ George","year":"2015","unstructured":"George TJ, Allegra CJ, Yothers G (2015) Neoadjuvant rectal (NAR) score: a new surrogate endpoint in rectal cancer clinical trials. Curr Colorectal Cancer Rep 11:275\u2013280","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"12","key":"5142_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123209","volume":"15","author":"MA Gambacorta","year":"2023","unstructured":"Gambacorta MA, Chiloiro G, Masciocchi C, Mariani S, Romano A, Gonnelli A et al (2023) pCR and 2-year disease-free survival: a combination of the two endpoints as a new classification for locally advanced rectal cancer patients\u2014an updated pooled analysis of eleven international randomized trials. Cancers Basel 15(12):3209","journal-title":"Cancers Basel"},{"issue":"7","key":"5142_CR33","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.ejca.2010.12.015","volume":"47","author":"D Sargent","year":"2011","unstructured":"Sargent D, Shi Q, Yothers G, Van Cutsem E, Cassidy J, Saltz L et al (2011) Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803. Eur J Cancer 47(7):990\u20136","journal-title":"Eur J Cancer"},{"issue":"3","key":"5142_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.radonc.2015.02.001","volume":"114","author":"V Valentini","year":"2015","unstructured":"Valentini V, Van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M et al (2015) Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer. Radiother Oncol 114(3):302\u2013309","journal-title":"Radiother Oncol"},{"key":"5142_CR35","doi-asserted-by":"publisher","unstructured":"Fokas E, Smith JJ, Garcia-Aguilar J, Glynne-Jones R, Buyse M, R\u00f6del C (2024) Early efficacy end points in neoadjuvant rectal cancer trials: surrogacy revisited. J Clin Oncol 42(8):872\u2013875. https:\/\/doi.org\/10.1200\/JCO.23.01196","DOI":"10.1200\/JCO.23.01196"},{"issue":"1","key":"5142_CR36","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2016.11.03","volume":"8","author":"F Petrelli","year":"2017","unstructured":"Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Barni S (2017) Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials. J Gastrointest Oncol 8(1):39","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"5142_CR37","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1097\/SLA.0000000000005799","volume":"278","author":"EA Dijkstra","year":"2023","unstructured":"Dijkstra EA, Nilsson PJ, Hospers GA, Bahadoer RR, Kranenbarg EM, Roodvoets AG, Putter H, Berglund \u00c5, Cervantes A, Crolla RM, Hendriks MP (2023Oct 1) Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial. Annals of surgery. 278(4):e766-72","journal-title":"Annals of surgery."},{"issue":"2","key":"5142_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","volume":"15","author":"J-F Bosset","year":"2014","unstructured":"Bosset J-F, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun R-J et al (2014) Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 15(2):184\u2013190","journal-title":"Lancet Oncol"},{"issue":"2","key":"5142_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","volume":"16","author":"AJ Breugom","year":"2015","unstructured":"Breugom AJ, Swets M, Bosset J-F, Collette L, Sainato A, Cionini L et al (2015) Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol 16(2):200\u2013207","journal-title":"Lancet Oncol"},{"issue":"1","key":"5142_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijrobp.2007.12.019","volume":"72","author":"C Capirci","year":"2008","unstructured":"Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R et al (2008) Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. International Journal of Radiation Oncology Biology Physics. 72(1):99\u2013107","journal-title":"International Journal of Radiation Oncology Biology Physics."},{"issue":"1","key":"5142_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/cncr.30261","volume":"123","author":"Z Xu","year":"2017","unstructured":"Xu Z, Mohile SG, Tejani MA, Becerra AZ, Probst CP, Aquina CT et al (2017) Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: an NCDB analysis. Cancer 123(1):52\u201361","journal-title":"Cancer"},{"key":"5142_CR42","first-page":"1","volume":"2021","author":"J-y Li","year":"2021","unstructured":"Li J-y, Huang X-z, Gao P, Chen X-w, Song Y-x, Lv X-e et al (2021) Postoperative adjuvant treatment strategy for locally advanced rectal cancer after neoadjuvant treatment. BioMed Res Int 2021:1\u201321","journal-title":"BioMed Res Int"},{"key":"5142_CR43","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A et al (2017) Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv22\u2013iv40","journal-title":"Ann Oncol"},{"issue":"1","key":"5142_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00521-5","volume":"11","author":"PS Pezeshki","year":"2023","unstructured":"Pezeshki PS, Ghalehtaki R (2023) The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer. Biomark Res 11(1):81","journal-title":"Biomark Res"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-026-05142-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-026-05142-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-026-05142-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:55:04Z","timestamp":1782168904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-026-05142-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5142"],"URL":"https:\/\/doi.org\/10.1007\/s00384-026-05142-6","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the ethical regulations by the Declaration of Helsinki and was approved by the institutional review board (#1402-2-495-67291) and the ethics committee of Tehran University of Medical Sciences (IR.TUMS.IKHC.REC.1402.253). All patients provided written and informed consent on admission regarding the use of their personal data for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}